Stay updated on Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial
Sign up to get notified when there's something new on the Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial page.

Latest updates to the Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial page
- Check3 days agoChange DetectedRevision tag changed from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoChange DetectedThe history page now includes a glossary toggle and color-coded highlights for additions (green) and deletions (red), along with the updated Revision: v3.4.0 and revised No FEAR Act labeling.SummaryDifference0.4%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No other content changes are visible.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision: v3.3.3 was added and the HHS Vulnerability Disclosure link was removed from the footer. These are maintenance updates and do not affect trial data or functionality.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Contacts/Locations and Study Status sections on 2025-12-12 and removed the item dated 2025-10-15.SummaryDifference0.2%

- Check68 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed from the history, reflecting an administrative update to the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial page.